课题基金 / 基金详情

Reducing Tunneled Dialysis Catheter Dysfunction through Nitric Oxide Release

Reducing Tunneled Dialysis Catheter Dysfunction through Nitric Oxide Release
通过释放一氧化氮减少隧道式透析导管功能障碍
批准号:
9188634
负责人:
MARK E MEYERHOFF
金额:
$7.67万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-30 至 2017-08-31

项目摘要

项目成果

MARK E MEYERHOFF的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Tunneled Dialysis Catheters (TDCs) are an important mode of dialysis vascular access. 80% of incident dialysis patients begin hemodialysis with a TDC and the overall prevalence in the US is approximately 25%. Unfortunately, TDCs have huge problems with infection, thrombosis and central venous stenosis, which results in a very significant morbidity, mortality and economic cost. Despite the magnitude of the clinical problem, however, there are no effective therapies for TDC dysfunction. Nitric oxide (NO) is an important biological mediator, which has potent anti-bacterial, anti-platelet aggregation and anti-smooth muscle cell proliferation activities, which could potentially reduce TDC complications. We have previously developed a novel and innovative technology to electrochemically modulate NO release (within a catheter lumen); in which a copper electrode embedded in a nitrite solution is able to generate NO (through the interaction between Cu ions and nitrite) over a prolonged period of time. The central hypothesis of this proposal, is that the electrochemically modulated release of NO from a lumen within a TDC could target all three major complications associated with TDC use (infection, thrombosis and central vein stenosis); thus significantly reducing the huge morbidity, mortality and economic cost associated with TDC use. We plan to address this central hypothesis through a series of specific aims that focus on (a) the development and validation (within a TDC lumen) of an electrochemically modulated NO release system with biological activity (b) reducing infection, thrombosis and central vein stenosis with NO releasing TDCs in-vivo, in a pig model. We believe that there is a huge unmet clinical need for novel therapies that reduce TDC dysfunction and feel that the concept of NO releasing TDCs could significantly reduce the huge clinical morbidity and economic cost associated with this intractable problem.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Advanced Thromboresistant/Bactericidal Catheters via Electromodulated NO Release
Intravascular Chemical Sensors with Improved Biocompatiblity/Performance via Nitric Oxide Release
Amperometric NO(g) Sensors with Improved Selectivity/Sensitivity for Biomedical Measurements
Amperometric NO(g) Sensors with Improved Selectivity/Sensitivity for Biomedical Measurements
海外基金